European Biotech News
Shares of the biotech firm NicOx have been pummeled after an EU panel rejects their anti-inflammatory treatment naproxcinod. The French company said it would drop its European application for the trea…
Biotech & more
Shares of the biotech firm NicOx have been pummeled after an EU panel rejects their anti-inflammatory treatment naproxcinod. The French company said it would drop its European application for the trea…
Goodwin Biotechnology, Inc. is a fully integrated contract manufacturer of monoclonal antibodies and vaccines; Goodwin Biotechnology has the experience and expertise in development of recombinant prot…
Tanzania has the best technology regulator regimes which are likely to be destabilized for commercial interests. Mr Moses Shaha, Regional Chairman Eastern and Southern Africa Small Scale Farmers' …
Seattle based company Geospiza has been around the block a time or two in the bioinformatics business, and after 14 years in the game, it has come to the end of the road.
The bioinformatics company, …
New research shows that as of today, the biotech world puts a great deal of emphasis on clinical development and regulatory affairs jobs. According to an article by the Economic Times two of biotech…
Biotech employees are among the most happy with their daily tasks and the level of control they feel they have over that work. A new study reveals employees value coworkers and personal control over c…
A war of sorts is all set between the environmentalists and biotech Company Scripps Florida over the last remaining forest land in eastern Palm Beach. Environmental activists are against the developme…
Major pharmaceutical company Sanofi-Aventis SA has acquired Genzyme after a lengthy courtship, but now that the deal is done, making the merger work is fraught with pitfalls. Similar deals have shown …
Industry analysts state that China's biomedicine industry saw an increase of about 44 percent in its gross output value last year, and they also forecast that the biomedicine industry will see a…
The latest biotech research report from RNCOS Industry
Research Solutions shows that there is a big chance for a 13% CAGR growth for Singapore's biotech market until 2012.
Considering that t…